Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **neuronal acetylcholine receptor subunits alpha-3 and beta-4** form the heteropentameric **α3β4 nicotinic acetylcholine receptor**, a ligand-gated ion channel highly enriched in **autonomic ganglia** and the **adrenal medulla**. Activation by acetylcholine or exogenous agonists opens a transmembrane pore, allowing rapid cation (Na^+, K^+, and some Ca^2+^) influx, mediating fast excitatory synaptic transmission in the peripheral and select central circuits. This receptor modulates autonomic function and participates in neural circuits related to reward and addiction. α3β4-selective antagonists and modulators are being investigated as therapeutics for substance use disorders, though off-target effects due to the wide distribution of autonomic neurons present challenges for clinical applications[2][4][6][8].
Agonists bind to the extracellular domain at the α3/β4 interface, inducing a conformational change that opens the ion channel, permitting cation influx and neuronal depolarization[1][4]. Antagonists block the agonist-binding site or the ion pore, inhibiting channel opening and reducing neuronal excitability or synaptic transmission[2][4].
28 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal acetylcholine receptor subunit alpha-3 and Neuronal acetylcholine receptor subunit beta-4 (nAChR α3β4).